Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kadcyla
Pharma
ESMO: Enhertu wields 2-fisted power in early breast cancer
The AstraZeneca and Daiichi star ADC showed strong efficacy separately as neoadjuvant and adjuvant therapy in HER2-positive early breast cancer.
Angus Liuu
Oct 18, 2025 10:30am
Overall survival data blur Seagen's Tukysa-ADC path
Dec 6, 2023 8:15am
Seagen's breast cancer drug Tukysa boosts Roche's ADC
Aug 17, 2023 10:18am
Daiichi Sankyo dials up Enhertu projection
Oct 31, 2022 12:17pm
AZ, Daiichi's Enhertu, after 2 recent nods, notches trial win
Aug 15, 2022 11:45am
AZ, Daiichi's Enhertu leaps into 2L breast cancer
May 5, 2022 7:55am
